IP Library Granted Patent US 12,365,691
Granted Patent B2
US 12,365,691 · App. 18/298,226 · Granted Jul 22, 2025

Method of synthesizing (3S,3AR,5R,7AS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-ol

Inventors: Arun K. Ghosh (West Lafayette, IN); Shivaji Markad (West Lafayette, IN)
Assignee: Purdue Research Foundation
C07D493/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,365,691
App. No.
18/298,226
Granted
Jul 22, 2025
Kind
B2
Abstract

The disclosure relates to a method of synthesizing the high-affinity, non-petidyl ligand (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-ol, which is useful in the synthesis of various compounds, such as HIV-1 protease inhibitors.

Claims (68)

1. A method of making a compound of the formula (I):

or a salt thereof, with an enantiomeric excess (ee) of at least 90%;

wherein:

X 1 is alkylene, —O—, —CH 2 NR 1 — or —NHR 1 —, wherein R 1 is alkyl, aryl or heteroaryl, and

R 2 is hydroxy, alkoxy or amido;

the method comprising

(i) converting a compound of the formula (II):

or a salt thereof,

to a compound of the formula (III):

or a salt thereof;

(ii) converting the compound of formula (III), or a salt thereof, to a compound of the formula (IV):

or a salt thereof; and

(iii) converting the compound of formula (IV), or a salt thereof, to the compound of the formula (I).

2. The method of claim 1 , wherein the converting in step (i) comprises ring opening of the compound of the formula (II).

3. The method of claim 1 , wherein the converting in step (ii) comprise reducing the compound of formula (III) to a compound of the formula (IV), or a salt thereof.

4. The method of claim 1 , wherein the converting in step (iii) comprises ozonolysis of the compound of formula (IV), or a salt thereof, to give an ozonolysis product, or a salt thereof.

5. The method of claim 4 , further comprising reducing the ozonolysis product, or a salt thereof, to obtain the compound of the formula (I).

6. The method of claim 4 , wherein the ozonolysis product is of the formula (V):

or a salt thereof.

7. The method of claim 1 , wherein X 1 is alkylene.

8. The method of claim 7 , wherein alkylene is a C 1 -C 3 (alkylene) group.

9. The method of claim 8 , wherein the alkylene is —CH 2 —.

10. The method of claim 1 , wherein X 1 is alkylene and R 2 is hydroxy.

11. A method of making a compound of the formula (VI):

or a salt thereof, with an enantiomeric excess (ee) of at least 90%;

wherein:

X 1 is alkylene, —O—, —CH 2 NR 1 — or —NHR 1 —, wherein R 1 is alkyl, aryl or heteroaryl;

the method comprising:

(i) converting a compound of the formula (I):

or a salt thereof,

wherein:

X 1 is alkylene, —O—, —CH 2 NR 1 — or —NHR 1 —, wherein R 1 is alkyl, aryl or heteroaryl, and

R 2 is hydroxy, alkoxy or amido,

to a compound of the formula (VII):

or a salt thereof, wherein X 2 is O or CH 2 ; and

(ii) converting the compound of formula (VII), or a salt thereof, to a compound of the formula (VI), or a salt thereof.

12. The method of claim 11 , further comprising (iii) converting the compound of the formula (I) to a compound of the formula (VIII):

or a salt thereof,

wherein:

X 1 is alkylene —O—, —CH 2 NR 1 — or —NHR 1 —, wherein R 1 is alkyl, aryl or heteroaryl, and

R 3 is hydroxyalkyl or COR 2 , wherein R 2 is hydroxy, alkoxy or amido; and

(iv) converting the compound of the formula (VIII) to the compound of the formula (VII), wherein X 2 is CH 2 .

13. The method of claim 12 , wherein R 3 is —CH 2 OH.

14. The method of claim 12 , further comprising (v) converting the compound of the formula (VII), or a salt thereof, wherein X 2 is CH 2 to the compound of the formula (VII), or a salt thereof, wherein X 2 is O.

15. The method of claim 11 , wherein X 1 is alkylene.

16. The method of claim 14 , wherein alkylene is a C 1 -C 3 (alkylene) group.

17. The method of claim 15 , wherein the alkylene is —CH 2 —.

18. The method of claim 11 , further comprising (vi) converting the compound of formula (VI), or a salt thereof, to a compound of the formula (IX):

or a salt thereof, wherein R 4 is optionally substituted aryl.

19. The method of claim 18 , further comprising conjugating the compound of the formula (IX), or a salt thereof, with a compound of the formula (X):

or a salt thereof, wherein:

n is an integer from 1 to 3;

R 5 is alkoxy, hydroxyalkyl, halo or heterocyclylalkyloxy;

R 6 is alkyl, haloalkyl, arylalkyl, cycloalkylalkyl, heterocyclylcarbonyl or heterocyclylalkyl; and

R 7 is aryl or heteroaryl, to give a compound of the formula (XI):

or a salt thereof.

20. A method of making a compound of the formula (VIII):

or a salt thereof, with an enantiomeric excess (ee) of at least 90%;

wherein:

X 1 is alkylene —O—, —CH 2 NR 1 — or —NHR 1 —, wherein R 1 is alkyl, aryl or heteroaryl, and

R 3 is hydroxyalkyl or COR 2 , wherein R 2 is hydroxy, alkoxy or amido;

the method comprising:

(i) converting a compound of the formula (I):

or a salt thereof,

wherein:

X 1 is alkylene —O—, —CH 2 NR 1 — or —NHR 1 —, wherein R 1 is alkyl, aryl or heteroaryl; and

R 2 is hydroxy, alkoxy or amido,

to a compound of the formula (VIII).

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 23, 2024
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066365/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2023
From: GHOSH, ARUN K.; MARKAD, SHIVAJI
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 063798/0271 →
Continuity (2)
Provisional Application 63350960 · Jun 10, 2022
Related Publication 20230399338A1 · Dec 14, 2023
References Cited (11)
US 20220363688A1 · Ghosh · 2022 [cited by examiner]
WO 2015175994 · 2015 [cited by applicant]
WO 2022119858 · 2022 [cited by applicant]
WO 2022251615 · 2022 [cited by applicant]
Qabaja et al., Asymmetric Synthesis of Hydroxy Esters with Multiple Stereocenters via a Chiral Phosphoric Acid Catalyzed Kinetic Resolution, 2015, Journal of Organic Chemistry, vol. 80, pp. 133-140. (Year: 2015). [cited by examiner]
“European Application Serial No. 23178284.8, Extended European Search Report mailed Oct. 30, 2023”, 9 pgs. [cited by applicant]
“European Application Serial No. 23178284.8, Response filed Jun. 13, 2024 to Extended European Search Report mailed Oct. 30, 2023”, 12 pgs. [cited by applicant]
“European Application Serial No. 23178284.8, Communication Pursuant to Article 94(3) EPC mailed Aug. 20, 2024”, 4 pgs. [cited by applicant]
Ghosh, Arun K., “A convenient synthesis of (3S,3aR,5R,7aS,8S)-Hexahydro-4H-3,5-methan ofuro[2,3-b]pyran-8-ol, a high-affinity nonpeptidyl ligand for highly potent HIV-1 protease inhibitors”, Tetrahedron Letters, Elsevie… [cited by applicant]
Gosh, A K, “Design and Development of highly potent HIV-1 protease inhibitors with a crown-like oxotricyclic core as the P2-ligand to combat multidrug-resistant HIV variants”, Journal of Medicinal Chemistry, vol. 60, (A… [cited by applicant]
Marzijarani, Nastaran, “New Mechanism for Cinchona Alkaloid-Catalysis Allows for an Efficient Thiophosphorylation Reaction”, J. Am. Chem. Soc. 2020, 142, 47, 20021-20029., (Nov. 12, 2020), 118 pgs. [cited by applicant]